QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, H. H. Articles by McLoon, S. C. Search for Related Content PubMed PubMed Citation Articles by Wu, H. H. Articles by McLoon, S. C.

 Previous Article  |  Next Article 

Journal of Neuroscience, Vol 14, 4806-4814, Copyright © 1994 by Society for Neuroscience

ARTICLE

Implantation of AtT-20 or genetically modified AtT-20/hENK cells in mouse spinal cord induced antinociception and opioid tolerance

HH Wu, GL Wilcox and SC McLoon
Department of Pharmacology, University of Minnesota, Minneapolis 55455.

AtT-20 cells, which make and release beta-endorphin, or AtT-20/hENK cells, an AtT-20 cell line transfected with the human proenkephalin gene and secreting enkephalin as well as presumably beta-endorphin, were implanted in mouse spinal subarachnoid space. Cell implants did not affect the basal response to thermal nociceptive stimuli. Administration of isoproterenol, believed to stimulate secretion from these cells, produced antinociception in groups receiving AtT-20 or AtT- 20/hENK cell implants but not in control groups receiving no cells. The antinociceptive effect of isoproterenol was dose related and could be blocked by the opioid antagonist naloxone. Implantation of these cells offers a novel approach for the study of tolerance. Mice receiving AtT- 20 cell implants developed tolerance to beta-endorphin and the mu- opioid agonist DAMGO, whereas mice receiving genetically modified AtT- 20/hENK cell implants developed tolerance to the delta-opioid agonist DPDPE. Genetically modified AtT-20/hENK cell implants, but not AtT-20 cell implants, reduced the development of acute morphine tolerance in the host mice. This finding is consistent with the suggestion that enkephalin alters development of opioid tolerance. These results suggest that opioid-releasing cells implanted around mouse spinal cord can produce antinociception and may provide an alternative therapy for chronic intractable pain.

This article has been cited by other articles:

				G.-S. Liu, L.-F. Liu, C.-J. Lin, J.-C. Tseng, M.-J. Chuang, H.-C. Lam, J.-K. Lee, L.-C. Yang, J. H. Y. Chan, S.-L. Howng, et al. Gene Transfer of Pro-opiomelanocortin Prohormone Suppressed the Growth and Metastasis of Melanoma: Involvement of {alpha}-Melanocyte-Stimulating Hormone-Mediated Inhibition of the Nuclear Factor {kappa}B/Cyclooxygenase-2 Pathway Mol. Pharmacol., February 1, 2006; 69(2): 440 - 451. [Abstract] [Full Text] [PDF]

				R. Likar, S. A. Mousa, G. Philippitsch, H. Steinkellner, W. Koppert, C. Stein, and M. Schafer Increased numbers of opioid expressing inflammatory cells do not affect intra-articular morphine analgesia Br. J. Anaesth., September 1, 2004; 93(3): 375 - 380. [Abstract] [Full Text] [PDF]

				C. A. Fairbanks and G. L. Wilcox Acute Tolerance To Spinally Administered Morphine Compares Mechanistically with Chronically Induced Morphine Tolerance J. Pharmacol. Exp. Ther., September 1, 1997; 282(3): 1408 - 1417. [Abstract] [Full Text]

				K. Johanning, J. P. Mathis, and I. Lindberg Processing Site Blockade Results in More Efficient Conversion of Proenkephalin to Active Opioid Peptides J. Biol. Chem., November 1, 1996; 271(44): 27871 - 27878. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help